Uncategorised - European Medical Journal

Continue
27 Oct 2016

Introducing EMJ Diabetes 4.1

United Kingdom, October 27, 2016: Welcome to the newest edition of EMJ Diabetes, filled with interviews, abstracts, peer-reviewed papers, and the most…
EMJ
27 Oct 2016

Prize Winners at the 52nd EASD Annual Meeting 2016

The EASD Annual Meeting saw the presentation of several major prizes and research fellowships. In this section we introduce you to the distinguished…
17 Mins
27 Oct 2016

Review of the 52nd European Association for the Study of Diabetes Congress 2016

As the location of the head office of the German Center for Diabetes Research (DZD) and the Institute of Diabetes and Regeneration Research (IDR), Munich…
13 Mins
27 Oct 2016

Type 2 Diabetes Mellitus: Beyond the Beta Cell

Type 2 diabetes mellitus (T2DM) currently affects >8% of the world population. It is the leading cause of blindness, end-stage kidney disease, and…
9 Mins
27 Oct 2016

Editor’s Pick: New Drugs for Type 2 Diabetes: New Hopes and New Concerns About the Skeleton

There is growing evidence indicating the effects of medications for Type 2 diabetes mellitus (T2DM) on bone metabolism and fracture risk.
10 Mins
27 Oct 2016

Treatment of Type 2 Diabetes with Biphasic Insulin Analogues

The majority of patients with Type 2 diabetes require insulin therapy for treating hyperglycaemia. There are several regimens available for insulin…
10 Mins
27 Oct 2016

Utility of Glycated Haemoglobin in Gestational Diabetes Mellitus: Present and Future

Gestational diabetes mellitus (GDM) is a major public health problem with various complexities involved in its diagnosis. Traditionally an oral glucose…
9 Mins
27 Oct 2016

Treatment Strategies for Chorioretinal Vascular Diseases: Advantages and Disadvantages of Individualised Therapy

Chorioretinal vascular diseases are among the leading causes of blindness in industrialised countries. The recent development and widespread adoption of…
8 Mins
27 Oct 2016

Anti-Hyperglycaemic and Lipid Profile Regulatory Properties of Moringa Oleifera in Subjects at Early Stages of Type 2 Diabetes Mellitus

Moringa oleifera leaf powder (MOLP) was incorporated into patient diets in order to study its effects on the levels of fasting blood glucose (FBG)…
EMJ
26 Oct 2016

Congress Review – EASD 2016

Read our congress review in our EMJ Diabetes 4.1 2016 eJournal, available now…